Transdermal delivery of CaCO3-nanoparticles containing insulin

Diabetes Technology and Therapeutics

Volumn 8, Issue 3, 2006, Pages 369-374

  Higaki, Megumu ^a   Kameyama, Mieko ^a   Udagawa, Masae ^a   Ueno, Yukio ^a   Yamaguchi, Yoko ^b   Igarashi, Rie ^b   Ishihara, Tsutomu ^a   Mizushima, Yutaka ^a,b  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; NANOPARTICLE; CALCIUM CARBONATE; NANOMATERIAL; RECOMBINANT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; ENZYME IMMUNOASSAY; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; INSULIN TREATMENT; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; BLOOD; INTRADERMAL DRUG ADMINISTRATION; MOUSE STRAIN;

ADMINISTRATION, CUTANEOUS; ANIMALS; CALCIUM CARBONATE; INSULIN; MICE; MICE, INBRED STRAINS; NANOSTRUCTURES; RECOMBINANT PROTEINS;

EID: 33748434379     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/dia.2006.8.369     Document Type: Article

References (15)

1. Chetty DJ, Chien YW: Novel methods of insulin delivery, an update. Crit Rev Ther Drug Carrier Syst 1998;15:629-670.
2. Hoffman A, Ziv E: Pharmokinetic considerations of new insulin formulations and routes of administration. Clin Pharmacokinet 1997;33:285-301.
3. Ogiso T, Iwaki M, Tanino T, Nishioka S, Higashi K, Kamo M: In vitro skin penetration and degradation of enkephalin, elcatonin and insulin. Biol Pharm Bull 1997;20:54-60.
4. Cevc G, Gebauer D, Stieber J, Schatzlein A, Blume G: Ultraflexible vesicles, transfersomes, have an extremely low pore penetration resistance and transport therapeutic amounts of insulin across the intact mammalian skin. Biochim Biophys Acta 1998;1368:201-215.
5. Cevc G: Transdermal drug delivery of insulin with ultradeformable carriers. Clin Pharmacokinet 2003;42:461-474.
6. King MJ, Badea I, Solomon J, Kumar P, Gaspar KJ, Foldvari M: Transdermal delivery of insulin from a novel biphasic lipid system in diabetic rats. Diabetes Technol Ther 2002;4:479-488.
7. Miyazaki S, Takahashi T, Kubo W, Bachynsky J, Lobenberg R: Poly n-butylcyanoacrylate (PNBCA) nanocapsules as a carrier for NSAIDs: in vitro release and in vivo skin penetration. J Pharm Pharm Sci 2003;6:240-245.
8. Yamaguchi Y, Nagasawa T, Nakamura T, Takenaga M, Mizoguchi M, Kawai S, Mizushima Y, Igarashi R: Successful treatment of photo-damaged skin of nanoscale atRA particles using a novel transdermal delivery. J Control Release 2005;104:29-40.
9. Ueno Y, Futagawa H, Takagi Y, Ueno A, Mizashima Y: Drug-incorporating calcium carbonate nanoparticles for a new delivery system. J Control Release 2005;103:93-98.
10. Yanagawa A, Kudo T, Mizushima Y: A novel particle carrier for transnasal peptide absorption. Jpn J Clin Pharmacol Ther 1995;26:127-128.
11. Jalon EG, Blanco-Prieto MJ, Ygartua P, Santoyo S: PLGA microparticles: possible vehicles for topical drug delivery. Int J Pharm 2001;226:181-184.
12. Haruta S, Hanafusa T, Fukase H, Miyajima H, Oki T: An effective absorption behavior of insulin for diabetic treatment following intranasal delivery using porous spherical calcium carbonate in monkeys and healthy human volunteers. Diabetes Technol Ther 2003;5:1-9.
13. Ogiso T, Nishioka S, Iwaki M: Dissociation of insulin oligomers and enhancement of percutaneous absorption of insulin. Biol Pharm Bull 1996;19:1049-1054.
14. Koyama Y, Bando H, Yamashita F, Takakura Y, Sezaki H, Hashida M: Comparative analysis of percutaneous absorption enhancement by d-limonene and oleic acid based on a skin diffusion model. Pharm Res 1994;11:377-383.
15. Guo J, Ping Q, Zhang L: Transdermal delivery of insulin in mice by using lecithin vesicles as a carrier. Drug Deliv 2000;7:113-116.